[300 Pages Report] Global molecular cytogenetics market demand is anticipated to be valued at US$ 2,761.9 Million in 2022, forecast a CAGR of 8.9% to be valued at US$ 6,469.2 Million from 2022 to 2032. Growth is attributed to the changing methodologies for disease diagnosis and rising awareness about viral diseases and increasing government funding in various regions. From 2016 to 2021 a CAGR of 10.3% was registered for the enterprise key management market.
| Data Points | Key Statistics |
|---|---|
| Growth Rate (2016 to 2021) | 10.3% CAGR |
| Projected Growth Rate (2022 to 2032) | 8.9% CAGR |
| Expected Market Value (2022) | US$ 2,761.9 Million |
| Anticipated Forecast Value (2032) | US$ 6,469.2 Million |
Molecular cytogenetics comprises molecular biology and cytogenetics. Cytogenetics refers to the study of chromosomes and molecular cytogenetics further involves the analysis of genetic variations or alterations through in-situ hybridization techniques. Molecular cytogenetics finds crucial applications in the fields of biology and medicine.
Molecular cytogenetics studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities, particularly in medicinal and cancer-related genetics. In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome.
Also, the virtual karyotyping technique is done in molecular cytogenetics to assess the entire genome for the changes in the number of copies of the genome. FISH & GISH are one of the most reliable techniques for analyzing chromosomes.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Growing Prevalence of Cancer to Boost the Growth of The Molecular Cytogenetics Market
Molecular cytogenetics provides a scan and analysis of the whole genome organization, its structure and behavior at high resolutions, and also the visualization of single peculiar genomic loci which is a major growth driver for the global molecular cytogenetics market.
The recent advances in the fields of molecular biology and cytogenetics have brought about several key developments in the research of mitosis and meiosis processes, chromosome structures and their subsequent manipulation, gene expression, regulation, and gene silencing techniques.
Molecular cytogenetics is primarily driven by cancer diagnostics which offers techniques for imaging in genetics, epigenetics, and cytology and can be utilized for chromosomal modifications. The increasing prevalence of cancer and subsequent requirement for accurate diagnosis is expected to boost the growth of the global molecular cytogenetics market from 2022 to 2032
Lack of Skilled professional May Impede the Growth of the Market
There are some factors that are expected to impede the growth of the molecular cytogenetics market over the analysis period, such as technical limitations and complexities associated with the equipment.
However, the high cost of cytogenetic instruments, and lack of awareness about advanced technological methodologies, especially in low and middle-income countries, and the high cost of sophisticated devices are also expected to hinder the market growth during the forecast period.
The growing demand for genetic tests is an opportunity for the global molecular cytogenetics market. However, strict regulatory frameworks and a lack of skilled professionals are some of the major challenges for the global molecular cytogenetics market.
Principal Consultant
Technically Advance Healthcare Sector in North America to Boost the Growth
North America is expected to accumulate a 31.2% revenue share in 2022. North America is the market leader regarding revenue in the global molecular cytogenetics market owing to the presence of a large number of clinical research laboratories and research & academic institutes.
The rise in the incidences of cancer, growing spending from government and private healthcare organizations, and improved healthcare infrastructure in this region also boost the molecular cytogenetics market.
For instance, the average probability of a woman in the United States acquiring breast cancer in her lifetime is about 13%. An estimated 234,030 new instances of lung cancer were discovered in 2018, and there are already 541,000 Americans who have been diagnosed with lung cancer at some time in their lives. These findings show the vast potential for development and expansion in the USA molecular cytogenetics market.
An Increase in R& D Activities in The Region Propels the Growth of the Market
According to Future Market Insights, Europe is expected to provide immense growth opportunities for molecular cytogenetics and is expected to accumulate 19.6% revenue in 2022.
Europe is expected to witness the largest market growth, owing to the presence of a huge population in need, a high birth rate, the rising caseload of pre and postnatal disorders, and an increasing number of cases of different types of cancer.
The growth of the market in the region is attributed to the increasing research and development activities, rise in government intervention, growing awareness regarding cancer molecular biomarkers, and improving healthcare infrastructure in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Asia is expected to show high growth rates in the next five years in the molecular cytogenetics market. Some of the factors driving the growth of molecular cytogenetics in emerging markets are the increasing demand for genetic tests, advancements in healthcare infrastructure, and a large patient pool in countries such as India and China.
Also, the large number of research centers in China and India and Research and Development (R&D) centers in Japan will lead to a rise in demand for high-quality of molecular cytogenetics. Japan is the major contributor to the global molecular cytogenetics market mainly due to the well-established collaborations between manufacturers and research laboratories. Also, the role of personalized medicine in the treatment of genetic or other disorders is gaining pace in developed countries and this factor is anticipated to unfold novel opportunities for the key players during the forecast period.
The new entrants in the molecular cytogenetics market are continually indulging in several collaborations and highly investing in research and development activities to provide more convenient solutions to industry verticals. Some of the major start-ups that are leading the development of the market are -Cepheid, Map my Genome, and Medgenome.
Some of the key participants present in the global molecular cytogenetics market include Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, Abbott Laboratories, Agilent Technologies, Biological Industries, and PerkinElmer Inc. among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, and Abbott Laboratories account for considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.9% from 2022 to 2032 |
| Expected Market Value (2022) | US$ 2,761.9 Million |
| Anticipated Forecast Value (2032) | US$ 6,469.2 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global molecular cytogenetics market to expand at an 8.9% value CAGR by 2032
North America is expected to be the most opportunistic with a 31.2% share of the total molecular cytogenetics market
Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, Abbott Laboratories are some prominent molecular cytogenetics market manufacturers.
1. Executive Summary | Molecular Cytogenetics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ million) Analysis, 2016 to 2021 4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Technique Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Technique Type, 2016 to 2021 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Technique Type, 2022 to 2032 5.3.1. Genomic In Situ Hybridization 5.3.2. Fluorescence In Situ Hybridization 5.3.3. Multicolour Fluorescence In Situ Hybridization 5.3.4. Multiplex Fluorescence In Situ Hybridization 5.3.5. Spectral Karyotyping 5.3.6. Comparative Genomic Hybridization 5.3.7. Array Comparative Genomic Hybridization 5.3.8. Other Molecular Cytogenetic Techniques 5.4. Y-o-Y Growth Trend Analysis By Technique Type, 2016 to 2021 5.5. Absolute $ Opportunity Analysis By Technique Type, 2022 to 2032 6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Product Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2016 to 2021 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2022 to 2032 6.3.1. Instruments 6.3.2. Reagents & Kits 6.4. Y-o-Y Growth Trend Analysis By Product Type, 2016 to 2021 6.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032 7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By End User, 2016 to 2021 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2022 to 2032 7.3.1. Pharmaceutical & Biotechnology Companies 7.3.2. Clinical Research Laboratories 7.3.3. Research & Academic Institutes 7.3.4. Hospitals 7.3.5. Diagnostic Centers 7.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021 7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 8. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ million) Analysis By Region, 2016 to 2021 8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. Middle East and Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Technique Type 9.2.3. By Product Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Technique Type 9.3.3. By Product Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Technique Type 10.2.3. By Product Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Technique Type 10.3.3. By Product Type 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. The United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Technique Type 11.2.3. By Product Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technique Type 11.3.3. By Product Type 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. Rest of Asia Pacific 12.2.2. By Technique Type 12.2.3. By Product Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technique Type 12.3.3. By Product Type 12.3.4. By End User 12.4. Key Takeaways 13. MEA Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Technique Type 13.2.3. By Product Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technique Type 13.3.3. By Product Type 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. The united Kingdom 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Technique Type 14.1.2.2. By Product Type 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Technique Type 14.2.2.2. By Product Type 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Technique Type 14.3.2.2. By Product Type 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Technique Type 14.4.2.2. By Product Type 14.4.2.3. By End User 14.5. Rest of Latin America 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Technique Type 14.5.2.2. By Product Type 14.5.2.3. By End User 14.6. Germany 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Technique Type 14.6.2.2. By Product Type 14.6.2.3. By End User 14.7. The United Kingdom 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Technique Type 14.7.2.2. By Product Type 14.7.2.3. By End User 14.8. France 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Technique Type 14.8.2.2. By Product Type 14.8.2.3. By End User 14.9. Spain 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Technique Type 14.9.2.2. By Product Type 14.9.2.3. By End User 14.10. Italy 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Technique Type 14.10.2.2. By Product Type 14.10.2.3. By End User 14.11. Rest of Europe 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Technique Type 14.11.2.2. By Product Type 14.11.2.3. By End User 14.12. China 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Technique Type 14.12.2.2. By Product Type 14.12.2.3. By End User 14.13. Japan 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Technique Type 14.13.2.2. By Product Type 14.13.2.3. By End User 14.14. South Korea 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Technique Type 14.14.2.2. By Product Type 14.14.2.3. By End User 14.15. Malaysia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Technique Type 14.15.2.2. By Product Type 14.15.2.3. By End User 14.16. Singapore 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Technique Type 14.16.2.2. By Product Type 14.16.2.3. By End User 14.17. Australia 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Technique Type 14.17.2.2. By Product Type 14.17.2.3. By End User 14.18. Rest of Asia Pacific 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Technique Type 14.18.2.2. By Product Type 14.18.2.3. By End User 14.19. GCC Countries 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Technique Type 14.19.2.2. By Product Type 14.19.2.3. By End User 14.20. South Africa 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Technique Type 14.20.2.2. By Product Type 14.20.2.3. By End User 14.21. Israel 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Technique Type 14.21.2.2. By Product Type 14.21.2.3. By End User 14.22. Rest of MEA 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Technique Type 14.22.2.2. By Product Type 14.22.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Technique Type 15.3.3. By Product Type 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Thermo Fisher Scientific Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. GeneDx 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. CytoTest Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Empire Genomics 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Abbott Laboratories 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Agilent Technologies 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Biological Industries 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. PerkinElmer Inc. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Bio-RAD Laboratories Inc. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. F. Hoffmann-La Roche AG 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Testing Equipment
January 2019
REP-GB-8329
June 2022
250 pages
Explore Healthcare Insights
View Reports
Molecular Cytogenetics Market
